Barely Significant
← all phrases

“borderline significant”

11,410 sentences · 11,410 papers · 14,072 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

borderline significantp = 0.0571.1× alphagold
The association between the WHO status and Problem‐focused coping was borderline significant ( p = 0.057) with patients with a WHO status of 1 ( β = −0.75; 95% CI[−1.268; −0.228]) or 2 ( β = −1.33; 95% CI [−2.330; 0.340], ie, somewhat restricted in activities) scoring lower on Problem‐focused coping than patients with a WHO status of 0 (ie, fully active). 4.
borderline significantp = 0.0571.1× alphagold
The symptom of “physical exhaustion” improved over time in the VGH-BPH1 group from 1.87 ± 0.69 to 1.56 ± 0.59 ( p = 0.005), and the posttreatment score for this symptom had a borderline significant difference between the two groups ( p = 0.057).
borderline significantp = 0.0571.1× alphagold
There was a significant between-group main effect ( F (2, 133) = 6.742, p = 0.002, η p 2 = 0.092) for MS 3 duration, a significant cue × group interaction effect ( F (2, 133) = 5.246, p = 0.006, η p 2 = 0.073) and a significant between-group main effect ( F (2, 133) = 9.746, p < 0.001, η p 2 = 0.128) for MS 3 coverage; and there was a significant cue × group interaction effect ( F (2, 133) = 3.369, p = 0.037, η p 2 = 0.048) and a borderline significant between-group main effect ( F (2, 133) = 2.935, p = 0.057, η p 2 = 0.042) for MS 4 coverage, and a significant cue × group interaction effect ( F (2, 133) = 5.669, p = 0.004, η p 2 = 0.079) and a significant between-group main effect ( F (2, 133) = 6.640, p = 0.002, η p 2 = 0.091) for MS 4 occurren
borderline significantP =0.0571.1× alphagold
Interestingly, meta-regression analyses revealed a borderline significant correlation between the reported effect sizes and the proportion of postmenopausal women in individual studies (slope=-0.543, P =0.057; Figure 5C ), suggesting a trend between a stronger beneficial effect with an increasing number of postmenopausal women enrolled in the original trials.